Biden’s Prescription Drug Pricing Approach Pushes for Value-Based Pricing
President Joe Biden’s plan for lowering drug prices includes tying a drug’s price to its therapeutic value, according to recent [...]
Register Now for ICER’s Tuesday Webinar on Myasthenia Gravis Therapies
The Institute for Clinical and Economic Review (ICER) will hold a webinar on Tuesday, August 24th at 2:00 PM ET. [...]
Could Germany’s Proposed Drug Pricing Reform Impact United States?
The German committee responsible for assessing drug efficacy and setting prices may cut the initial 12-month review time by 50%. [...]
Researchers Claim Drug Price Limits Won’t Impact Innovation, PhRMA Strongly Disagrees
In a recently published article, researchers at Bentley University and West Health conclude that limiting drug prices will not affect [...]
Vanderbilt Scientist and Aetion RWE Strategist Highlight Seven Solutions to Bolster FDA’s Accelerated Approval Process and Achieve Value-Based Pricing
Aetion’s Dr. Nirosha Mahendraratnam Lederer and Vanderbilt’s Dr. Stacie B. Dusetzina discuss how value-based pricing may be achieved using the [...]
Fitch Ratings Report Warns of Costly COVID-19 Aftermath for Payers, Patients, and Providers
Fitch Ratings released a report warning that the effects of the COVID-19 pandemic will be costly and possibly felt for [...]
National Academy of Sciences, Engineering and Medicine Released Pro-Pharma Report on $750 Million in Yearly Prescription Drug Waste Following Undisclosed Pharma Donations
Congress tasked the National Academy of Sciences, Engineering and Medicine with providing an impartial view of the $750 million in [...]
Bristol Myers Squibb Senior VP Discusses Career Journey, Leadership Style, and Improving Access to Drugs Globally
Ester Banque, senior vice president and head of Intercontinental Commercial at Bristol Myers Squibb, discusses her career path and evolving [...]
New Article Details $93.3 Billion Annual Costs in Drug Utilization Management
An article published in Health Affairs details the multibillion-dollar costs associated with inflated drug utilization management. The estimated $93.3 billion [...]
MMIT’s AIS Health Article Details Efficacy and Costs of Specialty Drugs
MMIT’s AIS Health recently published an article on specialty pharmacy. Employers are typically resistant to drugs commanding high price tags. [...]
Pfizer and BioNTech Raise Price of COVID-19 Vaccine as UK Orders Booster Shots, Pfizer’s 2021 Sales Hit $11.3 Billion
Pfizer and BioNTech announced a price increase for COVID-19 booster shots—from £18 to £22. The European Union and the United [...]
Researchers Evaluate Oncology Treatment Costs at the National Cancer Institute and Community Hospitals
Researchers evaluated costs associated with cancer treatment in community hospitals and at the National Cancer Insitute (NCI), noting variation in [...]
[JAMA Article] Doctors Unwillingly Promoted to Bill Collectors as Healthcare Affordability Concerns Persist
High healthcare costs in the United States are impacting all facets of the industry. A recent article, published in JAMA, [...]
COVID-19 Shakes Up Business, Prompts Employers to Consider Value-Based Care
The COVID-19 pandemic has accelerated the rise in healthcare costs. Now, employers are considering value-based care instead of traditional healthcare [...]
Biden’s HHS Considers Eliminating Medicare Drug Pricing Model Reliant on International Benchmarks
The US Department of Health and Human Services (HHS) is considering doing away with a Medicare drug pricing model established [...]
Register Today for Next Week’s Webinar on Medical Cost Trends During and Post-Pandemic
A virtual event on medical cost trends will take place on Thursday, August 12th at 1:00 PM EST. Speakers will [...]
NPC and CEVR Researchers Find That Patient Voices Are Missing in Discussions on Drug Coverage
Researchers at the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health (CEVR) [...]
PhRMA President and CEO Discusses Lowering Prescription Drug Prices Using Patient-Centered Medicare Legislation
PhRMA CEO and President Stephen Ubl discusses how new Medicare legislation could impact consumers at a time when patients continue [...]
Costly Oncology Drugs Face ICER Scrutiny and Calls for Value-Based Pricing
Novel drugs used in cancer treatment, including chimeric antigen receptor (CAR)-T cell therapies, are increasing in popularity. However, their cost [...]
Wyden’s Principles of Reform Include a US-Based Drug Pricing System
Senator Wyden is pushing for legislation that will reduce prescription drug prices, such as Biogen’s pricy Aduhelm. He’s noted that [...]
10-Year Hydrocortisone Tablet Overcharge and Pay-For-Delay Deal Lead to £266.4 Million in Fines
The UK Competition and Markets Authority (CMA) has fined hydrocortisone tablet manufacturers £266.4 million for overcharging the National Health Service [...]
New ISPOR Article Discusses Survey on the Impact of COVID-19 on HTAs and Payers
A new article, published in ISPOR’s Value in Health journal, discusses how the COVID-19 pandemic has impacted health technology assessments [...]
Wyden Seeks to Include Medicare Price Negotiation in Healthcare Legislation
Senate Finance Committee Chair Ron Wyden was adamant in his support for legislation that would allow Medicare to negotiate drug [...]
UK Seeks to Advance Cost-Effective Rare Disease Research, Allocates $340 Million to New Innovative Medicines Fund
The UK will expand its Cancer Drugs Fund by creating a new Innovative Medicines Fund. The fund will promote research [...]
Widespread Price-Gouging of COVID-19 Tests Continues According to New AHIP Study
A recent study conducted by America’s Health Insurance Plans (AHIP) found that healthcare systems continue to up-charge for COVID-19 tests, [...]